It is also worth noting that CTX in combination with PD-L1 antibody blockade using the 6E11 antibody clone has been shown to have increased efficacy in preclinical models of MC38 colorectal cancer; therefore, it is possible that this combination therapy may be suitable for other tumor types other than breast cancer48. Here, CD274 is linked to neoplasm.